Skip to main content
logo
Chongqing Lummy Pharmaceutical Co., Ltd. (SHE:300006)
China flag China · Delayed Price · Currency is CNY
9.92
+1.65 (19.95%)
Oct 28, 2026, 3:04 PM CST

SHE:300006 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Net Income
-119.47-134.71-87.8-8.93-68.71-100.53
Depreciation & Amortization
51.5751.9255.872.7776.4174.76
Other Amortization
2.31.951.262.651.781.42
Loss (Gain) From Sale of Assets
-0.03-0.03-0.49-0.45-0.250.03
Asset Writedown & Restructuring Costs
62.3562.3525.750.710.090.51
Loss (Gain) From Sale of Investments
21.1421.1418.88-85.74-5.78-47.92
Provision & Write-off of Bad Debts
4.284.282.06-1.69-5.59-1.42
Other Operating Activities
-2.797.256.98-14.5944.5466.98
Change in Accounts Receivable
49.2749.27239.8751.39142.18-54.29
Change in Inventory
39.5839.580.9927.64-46.6663.34
Change in Accounts Payable
-53.33-53.33-75.35-50.76-20.24118.1
Change in Other Net Operating Assets
---0.382.59-51.46-
Operating Cash Flow
31.2326.04185.0381.5357.13108.28
Operating Cash Flow Growth
9356.39%-85.93%126.94%42.70%-47.24%-51.78%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Capital Expenditures
-34.2-41.75-78.62-59.32-68.18-38.66
Sale of Property, Plant & Equipment
0.40.310.040.1600.74
Cash Acquisitions
---11.01---
Divestitures
00.78--12.29-78.12
Investment in Securities
-6.02-19.364.22-60.2980.2114.3
Other Investing Activities
15.418.557.074.641.812.69
Investing Cash Flow
-24.41-51.4-18.31-127.1113.82157.19

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Long-Term Debt Issued
-294.95391.6294.9352.5171
Short-Term Debt Repaid
------180.91
Long-Term Debt Repaid
--430.79-181.23-362.86-206.88-1,084
Lease Payments
-5.13-5.13-5.5-8.92-3.66-
Total Debt Repaid
-567-430.79-181.23-362.86-206.88-1,265
Net Debt Issued (Repaid)
-167.24-135.84210.37-67.96145.62-1,094
Issuance of Common Stock
9.11----1,065
Common Dividends Paid
-24.38-12.35-10.76-11.8-17.47-29.08
Other Financing Activities
22.1630.22-9.67-1.4837.9194.2
Financing Cash Flow
-160.36-117.96189.94-81.24166.0736.05

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Foreign Exchange Rate Adjustments
-2.25-0.960.440.572.77-0.86
Net Cash Flow
-155.8-144.29357.1-126.25239.79300.67

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
-2.97-15.71106.4122.21-11.0569.63
Free Cash Flow Growth
--379.04%---61.32%
Free Cash Flow Margin
-0.41%-2.02%13.37%2.48%-1.25%5.68%
Free Cash Flow Per Share
-0.00-0.010.100.02-0.010.07
Levered Free Cash Flow
66.3619.0168.2617.68211.44-66.92
Unlevered Free Cash Flow
73.227.6275.2125.48224.16-46.87
Free Cash Flow After Leases
-8.1-20.84100.913.29-14.7169.63

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash Income Tax Paid
21.3277.39126.87132.63114.96166.12
Change in Working Capital
11.8811.88162.6116.7914.64114.46